Vestor Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-27
| Closed | -$43K | – | 293 |
|
|
2025
Q4 | $43K | Buy |
+27
| New | +$15.3K | ﹤0.01% | 259 |
|
|
2025
Q2 | – | Sell |
-81
| Closed | -$40K | – | 286 |
|
|
2025
Q1 | $40K | Sell |
81
-2
| -2% | -$1.08K | ﹤0.01% | 253 |
|
|
2024
Q4 | $43K | Buy |
83
+8
| +11% | +$4.4K | ﹤0.01% | 270 |
|
|
2024
Q3 | $46K | Sell |
75
-3
| -4% | -$1.78K | ﹤0.01% | 239 |
|
|
2024
Q2 | $43K | Sell |
78
-25
| -24% | -$14.3K | ﹤0.01% | 242 |
|
|
2024
Q1 | $60K | Sell |
103
-175
| -63% | -$98.2K | 0.01% | 219 |
|
|
2023
Q4 | $148K | Sell |
278
-11
| -4% | -$5.32K | 0.01% | 141 |
|
|
2023
Q3 | $146K | Sell |
289
-172
| -37% | -$91.7K | 0.02% | 140 |
|
|
2023
Q2 | $241K | Sell |
461
-13,630
| -97% | -$7.36M | 0.03% | 113 |
|
|
2023
Q1 | $8.12M | Buy |
14,091
+6
| +0% | +$3.38K | 0.95% | 37 |
|
|
2022
Q4 | $7.76M | Sell |
14,085
-9,917
| -41% | -$5.25M | 0.94% | 38 |
|
|
2022
Q3 | $12.2M | Buy |
24,002
+90
| +0.4% | +$50.4K | 1.6% | 19 |
|
|
2022
Q2 | $13M | Buy |
23,912
+39
| +0.2% | +$21.5K | 1.58% | 24 |
|
|
2022
Q1 | $14.1M | Sell |
23,873
-4
| -0% | -$2.3K | 1.4% | 25 |
|
|
2021
Q4 | $15.9M | Buy |
23,877
+362
| +2% | +$226K | 1.52% | 20 |
|
|
2021
Q3 | $13.4M | Buy |
23,515
+122
| +0.5% | +$67K | 1.4% | 24 |
|
|
2021
Q2 | $11.8M | Buy |
23,393
+11
| +0% | +$5.19K | 1.24% | 31 |
|
|
2021
Q1 | $10.7M | Buy |
23,382
+3,437
| +17% | +$1.64M | 1.22% | 32 |
|
|
2020
Q4 | $9.29M | Buy |
19,945
+411
| +2% | +$193K | 1.12% | 32 |
|
|
2020
Q3 | $8.63M | Buy |
+19,534
| New | +$8.07M | 1.22% | 31 |
|
|
2020
Q1 | $6.55M | Buy |
23,095
+4,915
| +27% | +$1.55M | 1.28% | 29 |
|
|
2019
Q4 | $5.91M | Sell |
18,180
-315
| -2% | -$95.5K | 0.9% | 38 |
|
|
2019
Q3 | $5.39M | Buy |
18,495
+519
| +3% | +$149K | 0.91% | 38 |
|
|
2019
Q2 | $5.28M | Buy |
17,976
+43
| +0.2% | +$11.8K | 0.93% | 38 |
|
|
2019
Q1 | $4.91M | Buy |
17,933
+810
| +5% | +$202K | 0.9% | 40 |
|
|
2018
Q4 | $3.83M | Buy |
17,123
+7,003
| +69% | +$1.64M | 0.83% | 40 |
|
|
2018
Q3 | $2.47M | Sell |
10,120
-80
| -0.8% | -$18.4K | 0.48% | 58 |
|
|
2018
Q2 | $2.11M | Buy |
10,200
+10
| +0.1% | +$2.12K | 0.43% | 64 |
|
|
2018
Q1 | $2.1M | Buy |
10,190
+370
| +4% | +$77.7K | 0.44% | 64 |
|
|
2017
Q4 | $1.86M | Buy |
+9,820
| New | +$1.88M | 0.4% | 63 |
|
Other funds holding TMO
VCM
Vestor Capital's TMO Position: Q1 2026 in Review
Vestor Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 27 shares — an estimated $43K sold.
Vestor Capital first reported a position in TMO in Q4 2017 and held it in 30 quarters. The position peaked at $15.9M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Vestor Capital reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- Vestor Capital sold 27 Thermo Fisher Scientific shares in Q1 2026, an estimated $43K.
- Vestor Capital first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 30 quarters.
- Vestor Capital's Thermo Fisher Scientific position peaked at $15.9M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.